FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

24505004: Carcinoma, diffuse type (morphologic abnormality)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
41104019 Carcinoma, diffuse type en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
41105018 Adenocarcinoma, diffuse type en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
754149019 Carcinoma, diffuse type (morphologic abnormality) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1223511017 Adenocarcinoma - diffuse type en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1223512012 Carcinoma - diffuse type en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carcinoma, diffuse type Is a Adenoma AND/OR adenocarcinoma false Inferred relationship Some
Carcinoma, diffuse type Is a Malignant neoplasm, primary false Inferred relationship Some
Carcinoma, diffuse type Is a Malignant adenomatous neoplasm - category false Inferred relationship Some
Carcinoma, diffuse type Is a Primary malignant adenomatous neoplasm false Inferred relationship Some
Carcinoma, diffuse type Is a Malignant adenomatous neoplasm (morphologic abnormality) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Hereditary diffuse gastric cancer is a rare epithelial tumor of the stomach, characterized by the development of diffuse (signet ring cell) gastric cancer at a young age, associated with germline heterozygous mutations of CDH1, MAP3K6 and CTNNA1 genes. In early stages it presents with non-specific and vague symptoms, in advanced stages it may cause nausea and vomiting, dysphagia, loss of appetite, abdominal mass or weight loss. Women have an increased risk of lobular breast cancer as well. Associated morphology True Carcinoma, diffuse type Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start